Antioxidant enzyme and malondialdehyde levels in patients with panic disorder

被引:109
|
作者
Kuloglu, M
Atmaca, M
Tezcan, E
Ustundag, B
Bulut, S
机构
[1] Firat Univ, Fac Med, Dept Psychiat, Elazig, Turkey
[2] Firat Univ, Fac Med, Dept Biochem, Elazig, Turkey
[3] Firat Univ, Fac Med, Dept Neurol, Elazig, Turkey
关键词
panic disorder; antioxidant enzyme; malondialdehye;
D O I
10.1159/000067810
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is evidence of an etiopathogenetic role of free radicals (FRs) in some neuropsychiatric disorders. The aim of the present study was to determine whether the activity levels of some antioxidant enzymes [glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and catalase (CAT)] and malondialdehyde (MDA), a product of lipid peroxidation, were associated with panic disorder (PD). Twenty patients diagnosed with PD and 20 healthy controls were enrolled in this study. A clinical evaluation and measurements of GSH-Px SOD, CAT and MDA were performed. Additionally, all patients were assessed by the Panic Agoraphobia Scale (PAS). The mean GSH-Px, SOD and MDA levels of the patient group were significantly higher than those of the controls. There was a significant positive correlation between PAS scores and GSH-Px, SOD and MDA levels and between the duration of illness and SOD, CAT and MDA levels in the patient group. In conclusion, our results suggest that FRs may be involved in PD. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:186 / 189
页数:4
相关论文
共 50 条
  • [41] PANIC DISORDER IN RESPIRATORY PATIENTS
    POLLACK, MH
    KRADIN, R
    OTTO, MW
    WORTHINGTON, J
    SABATINO, S
    UCCELLO, R
    ROSENBAUM, JF
    PSYCHOSOMATICS, 1995, 36 (02) : 181 - 181
  • [42] PANIC DISORDER IN PATIENTS WITH DIZZINESS
    FROMMBERGER, UH
    TETTENBORN, B
    BULLER, R
    BENKERT, O
    ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (05) : 590 - 591
  • [43] SMOKING IN PATIENTS WITH PANIC DISORDER
    POHL, R
    YERAGANI, VK
    BALON, R
    LYCAKI, H
    MCBRIDE, R
    PSYCHIATRY RESEARCH, 1992, 43 (03) : 253 - 262
  • [45] Tiagabine improves panic and agoraphobia in panic disorder patients
    Zwanzger, P
    Baghai, TC
    Schüle, C
    Minov, C
    Padberg, F
    Möller, HJ
    Rupprecht, R
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (08) : 656 - 657
  • [46] Plasma catecholamine levels before and after paroxetine treatment in patients with panic disorder
    Oh, Jae-Young
    Yu, Bum-Hee
    Heo, Jung-Yoon
    Yoo, Ikki
    Song, Hyemin
    Jeon, Hong Jin
    PSYCHIATRY RESEARCH, 2015, 225 (03) : 471 - 475
  • [47] Priming panic interpretations in children of patients with panic disorder
    Schneider, S
    Unnewehr, S
    Florin, I
    Margraf, J
    JOURNAL OF ANXIETY DISORDERS, 2002, 16 (06) : 605 - 624
  • [48] Effects of selective serotonin reuptake inhibitors on cholesterol levels in patients with panic disorder
    Bailey, DL
    Le Mellédo, JM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (03) : 317 - 319
  • [49] MALONDIALDEHYDE LEVELS IN PATIENTS WITH CHRONIC PERIODONTITIS
    Gupta, Madhur
    Chari, Suresh
    Kolte, Abhay
    Chandankhede, Manju
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (24): : 4325 - 4328
  • [50] ARTERIAL EPINEPHRINE LEVELS IN PANIC DISORDER - REPLY
    VILLACRES, EC
    HOLLIFIELD, M
    KATON, WJ
    WILKINSON, CW
    VEITH, RC
    PSYCHIATRY RESEARCH, 1988, 25 (01) : 113 - 114